General Abstract & Application Information

Important 2016 Abstract & Application Dates

August 8		Regular Abstract & Late-Breaking Abstract Application Submission Period Closed
August 8		Young Investigator Award Abstract Submission Period Closed
August 8		New Cancer Immunotherapy Agents in Development Presentation Application Submission Period Closed
September 7		Late-Breaking Abstract Submission Period Opens*
September 21		Late-Breaking Abstract Submission Period Closes
September 26		Regular Abstract Titles Available via SITC 2016 Meeting App
November 8		Embargo Date (For Regular and Late-Breaking Abstracts)
November 8		Publish Date (Regular Abstracts ONLY)
December 8		Publish Date (Late-Breaking Abstracts ONLY)
*Those who were interested in submitting a Late-Breaking Abstract needed to submit an application by August 8, 2016. Only those who submitted an application will be eligible to submit during the Late-Breaking Abstract period.

31^st Annual Meeting Regular Abstract Information

Submission Period & Details

Regular abstracts were accepted from Friday, April 1 through Monday, August 8, 2016 at 11:59 p.m. EDT.

Highlights

• Young Investigator Awards are offered in conjunction with regular abstract submission

• Opportunity to give oral abstract presentations within Annual Meeting sessions

• All accepted abstracts will be available to 31^st Annual Meeting attendees in program materials and published in the Journal for ImmunoTherapy of Cancer, the Society's own global, open access, peer-reviewed journal

• 22 abstract categories, including Clinical Trials in Progress

Questions? Check out our list of FAQs!

31^st Annual Meeting Late-Breaking Abstract Information

Late-breaking abstract submission is solely for abstracts with late-breaking data and not for abstracts submitted "late". Those who were interested in submitting a Late-Breaking Abstract needed to submit an application by August 8, 2016. Only those who submitted an application will be eligible to submit during the Late-Breaking Abstract period. For information, click here.

New Cancer Immunotherapy Agents in Development Presentation Application

SITC accepted applications to present within the New Cancer Immunotherapy Agents in Development program taking place on November 9, 2016.  For information, click here.